Ulviprubart

· Abcuro, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ulviprubart, covering 2025-07-28 to 2025-07-28. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis [Phase 2, Phase 3]